Atalanta loads crossbow with $97M, targeting neuro trial starts for 2 RNAi therapies.
Saved in:
| Title: | Atalanta loads crossbow with $97M, targeting neuro trial starts for 2 RNAi therapies. |
|---|---|
| Authors: | Masson, Gabrielle (AUTHOR) |
| Source: | FierceBiotech. 1/28/2025, pN.PAG-N.PAG. 1p. |
| Database: | Business Source Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Description not available. |
